Who Paid My Doc
Monisha Banerjee
Colon & Rectal Surgery Lone Tree, CO Medical Doctor
NPI 1518370097 CMS profile 2782413
10103 Ridgegate Pkwy Ste 208, Lone Tree, CO 80124
General payments
$1,360
Research payments
$0
Ownership & investment interest
$0
Through program year 2024, Monisha Banerjee of Lone Tree, CO is reported in the CMS Open Payments database as having received $1,360 across 21 general payments and $0 in research payments paid to them.
No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.
General payments for this record sit in the 35th percentile of Colon & Rectal Surgery profiles with reported payments. Percentile describes the distribution, not the conduct.
By program year
2 rows| Year | Kind | Relative to this record's peak year | Amount | Records |
|---|---|---|---|---|
| 2024 | General | $1,333 | 19 | |
| 2023 | General | $27 | 2 |
Beside peers
- Monisha Banerjee
- Colon & Rectal Surgery median
- Middle half of Colon & Rectal Surgery
- National median
In program year 2025, general payments to Monisha Banerjee were reported at $0. Among 1,481 Colon & Rectal Surgery profiles paid that year, the median was $317 and the middle half received between $109 and $1,248.
Show as a table
| Year | Monisha Banerjee | Colon & Rectal Surgery median | Middle half | National median |
|---|---|---|---|---|
| 2019 | $0 | $443 | $125–$2,179 | $163 |
| 2020 | $0 | $167 | $53–$931 | $114 |
| 2021 | $0 | $207 | $72–$1,272 | $132 |
| 2022 | $0 | $341 | $111–$1,587 | $149 |
| 2023 | $27 | $322 | $115–$1,420 | $160 |
| 2024 | $1,333 | $328 | $112–$1,354 | $164 |
| 2025 | $0 | $317 | $109–$1,248 | $169 |
Breakdown
A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.
Billing to Medicare
Part B · data year 2024 · 23 billing codesPaid by Medicare
$15,993
Medicare patients
39
Services billed
76
| Condition among their Medicare patients | Relative to the most common | Share of patients |
|---|---|---|
| High blood pressure | 64% | |
| Arthritis | 62% | |
| Ischemic heart disease | 44% | |
| Depression | 41% | |
| Chronic kidney disease | 31% | |
| COPD | 28% | |
| Cancer | 28% | |
| Osteoporosis | 28% |
Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.
Records
21 reportedEvery payment, record by record
Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.
Other Colon & Rectal Surgery in Colorado
Eben Strobos
Colon & Rectal Surgery · Lakewood, CO
David Longcope
Colon & Rectal Surgery · Denver, CO
Daine Bennett
Colon & Rectal Surgery · Englewood, CO
Christopher Taylor
Colon & Rectal Surgery · Colorado Springs, CO
Warren Strutt
Colon & Rectal Surgery · Denver, CO
Michael McNevin
Colon & Rectal Surgery · Aurora, CO
Related records
Colon & Rectal Surgery in Colorado
Practitioners in the same specialty and state, ranked by reported value.
All Colon & Rectal Surgery
Everyone recorded under this specialty, nationwide.
Doctors in Colorado
Every practitioner in the state with a reported payment.
How to read this page
What each amount means, and what it does not mean.
What this means
U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.
An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.
Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.